These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22334838)

  • 1. Prevalence of endocrinopathies in patients with Beta-thalassaemia major - a cross-sectional study in oman.
    Mula-Abed WA; Al Hashmi H; Al Muslahi M; Al Muslahi H; Al Lamki M
    Oman Med J; 2008 Oct; 23(4):257-62. PubMed ID: 22334838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicentre study on prevalence of endocrine complications in thalassaemia major. Italian Working Group on Endocrine Complications in Non-endocrine Diseases.
    Clin Endocrinol (Oxf); 1995 Jun; 42(6):581-6. PubMed ID: 7634497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Blood Disorders Survey in the Sultanate of Oman.
    Al-Riyami A; Ebrahim GJ
    J Trop Pediatr; 2003 Jul; 49 Suppl 1():i1-20. PubMed ID: 12934793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study on endocrine dysfunction in thalassaemia.
    Ghosh S; Bandyopadhyay SK; Bandyopadhyay R; Roy D; Maisnam I; Ghosh MK
    J Indian Med Assoc; 2008 Oct; 106(10):655-6, 658-9. PubMed ID: 19552099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation (TIF).
    De Sanctis V; Eleftheriou A; Malaventura C;
    Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():249-55. PubMed ID: 16462705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre.
    Gamberini MR; De Sanctis V; Gilli G
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():158-69. PubMed ID: 19337172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indicators of Renal Glomerular and Tubular Functions in Patients with Beta-Thalassaemia Major: A cross sectional study at the Royal Hospital, Oman.
    Mula-Abed WA; Al-Hashmi HS; Al-Muslahi MN
    Sultan Qaboos Univ Med J; 2011 Feb; 11(1):69-76. PubMed ID: 21509211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrinopathies in adolescents with thalassaemia major receiving oral iron chelation therapy.
    Sharma R; Seth A; Chandra J; Gohain S; Kapoor S; Singh P; Pemde H
    Paediatr Int Child Health; 2016 Feb; 36(1):22-7. PubMed ID: 25311879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum ferritin levels and endocrinopathy in medically treated patients with β thalassemia major.
    Belhoul KM; Bakir ML; Saned MS; Kadhim AM; Musallam KM; Taher AT
    Ann Hematol; 2012 Jul; 91(7):1107-14. PubMed ID: 22281991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of endocrine complications in transfusion dependent thalassemia in Hospital Pulau Pinang: A pilot study.
    Lee KT; Lim SL; Goh AS
    Med J Malaysia; 2020 Jan; 75(1):33-37. PubMed ID: 32008017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron-endocrine pattern in patients with beta-thalassaemia.
    el-Hazmi MA; Warsy AS; al-Fawaz I
    J Trop Pediatr; 1994 Aug; 40(4):219-24. PubMed ID: 7932935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term Assessment of HSCT Effects on the Hypothalamus-Pituitary Axis in Pediatric Thalassemic Patients.
    Hamidieh AA; Mohseni F; Behfar M; Hamidi Z; Alimoghaddam K; Pajouhi M; Larijani B; Mohajeri-Tehrani MR; Ghavamzadeh A
    Arch Iran Med; 2018 Feb; 21(2):56-60. PubMed ID: 29664655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid Status in Children with Transfusion Dependent Hb-E β-Thalassaemia.
    Sharmin T; Mollah AH; Morshed AA; Chowdhury MK
    Mymensingh Med J; 2018 Apr; 27(2):348-357. PubMed ID: 29769501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-sectional and longitudinal study of the pituitary-thyroid axis in patients with thalassaemia major.
    Landau H; Matoth I; Landau-Cordova Z; Goldfarb A; Rachmilewitz EA; Glaser B
    Clin Endocrinol (Oxf); 1993 Jan; 38(1):55-61. PubMed ID: 8435886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of genotype on endocrine complications in thalassaemia major.
    Skordis N; Michaelidou M; Savva SC; Ioannou Y; Rousounides A; Kleanthous M; Skordos G; Christou S
    Eur J Haematol; 2006 Aug; 77(2):150-6. PubMed ID: 16800840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of endocrine disorders and their associated factors in transfusion-dependent thalassemia patients: a historical cohort study in Southern Iran.
    Bordbar M; Bozorgi H; Saki F; Haghpanah S; Karimi M; Bazrafshan A; Zekavat OR
    J Endocrinol Invest; 2019 Dec; 42(12):1467-1476. PubMed ID: 31228105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrinopathy in POEMS syndrome: the Mayo Clinic experience.
    Gandhi GY; Basu R; Dispenzieri A; Basu A; Montori VM; Brennan MD
    Mayo Clin Proc; 2007 Jul; 82(7):836-42. PubMed ID: 17605964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of puberty in Egyptian beta thalassemic patients: experience in north east region - Dakahlia province.
    Abdelrazik N; Ghanem H
    Hematology; 2007 Oct; 12(5):449-56. PubMed ID: 17852439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine complications in transfusion dependent thalassaemia in Penang Hospital.
    Ong CK; Lim SL; Tan WC; Ong EE; Goh AS
    Med J Malaysia; 2008 Jun; 63(2):109-12. PubMed ID: 18942294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth and puberty and its management in thalassaemia.
    De Sanctis V
    Horm Res; 2002; 58 Suppl 1():72-9. PubMed ID: 12373018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.